Uoppgitt
JM2 INVEST AS
Revenue 2025
NOK 99,000
Operating profit
NOK −249,000
Equity
NOK 1.3m
Incorporated
2021
Share capital
NOK 150,000
Roles
Daglig lederJohnny Eliassen
Regnskapsfører
Styrets lederJohnny Eliassen
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| JOHNNY ELIASSEN | 100.0% | 150.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| NYKODE THERAPEUTICS ASA | Active | 0.0% | 80000.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.